Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 338.00
-10.95 (-3.14%)
Oct 1, 2026, 3:30 PM IST
NSE:INDRAMEDCO Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 31,040 | 34,134 | 35,395 | 15,708 | 7,063 | 5,354 | |
Market Cap Growth | -23.88% | -3.56% | 125.33% | 122.39% | 31.94% | 8.75% |
Enterprise Value | 28,776 | 29,833 | 32,629 | 13,682 | 5,055 | 4,506 |
Last Close Price | 338.60 | 368.25 | 378.28 | 166.29 | 73.38 | 53.72 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.51 | 18.59 | 21.99 | 12.67 | 8.20 | 9.13 |
PS Ratio | 2.04 | 2.30 | 2.61 | 1.26 | 0.64 | 0.60 |
PB Ratio | 4.19 | 4.61 | 5.93 | 3.29 | 1.86 | 1.65 |
P/TBV Ratio | 4.19 | 4.61 | 5.94 | 3.30 | 1.87 | 1.65 |
P/FCF Ratio | 28.80 | 31.67 | 29.39 | 12.01 | 7.07 | 8.26 |
P/OCF Ratio | 18.54 | 20.39 | 22.58 | 7.85 | 4.89 | 5.68 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.89 | 2.01 | 2.41 | 1.10 | 0.46 | 0.51 |
EV/EBITDA Ratio | 10.54 | 11.35 | 13.57 | 7.17 | 3.42 | 3.89 |
EV/EBIT Ratio | 12.60 | 13.33 | 16.28 | 8.86 | 4.50 | 5.29 |
EV/FCF Ratio | 26.70 | 27.68 | 27.10 | 10.46 | 5.06 | 6.95 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.05 | 0.05 | 0.06 | 0.07 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.14 | 0.14 | 0.13 | 0.18 | 0.02 | 0.04 |
Debt / FCF Ratio | - | 0.34 | 0.27 | 0.26 | 0.03 | 0.08 |
Net Debt / Equity Ratio | -0.31 | -0.30 | -0.48 | -0.39 | -0.33 | -0.19 |
Net Debt / EBITDA Ratio | -0.83 | -0.85 | -1.19 | -0.98 | -0.84 | -0.52 |
Net Debt / FCF Ratio | - | -2.07 | -2.37 | -1.44 | -1.24 | -0.94 |
Asset Turnover | - | 1.61 | 1.72 | 1.95 | 2.16 | 1.99 |
Inventory Turnover | - | 76.15 | 72.70 | 63.08 | 50.21 | 43.34 |
Quick Ratio | - | 2.32 | 2.26 | 1.73 | 1.55 | 1.45 |
Current Ratio | - | 2.46 | 2.41 | 1.86 | 1.72 | 1.68 |
Return on Equity (ROE) | - | 27.47% | 29.97% | 28.92% | 24.44% | 19.60% |
Return on Assets (ROA) | - | 15.18% | 15.91% | 15.10% | 13.80% | 11.91% |
Return on Invested Capital (ROIC) | 32.98% | 40.34% | 49.67% | 42.25% | 31.73% | 24.26% |
Return on Capital Employed (ROCE) | - | 27.20% | 29.80% | 27.70% | 26.40% | 23.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.06% | 5.38% | 4.55% | 7.89% | 12.20% | 10.95% |
FCF Yield | 3.47% | 3.16% | 3.40% | 8.32% | 14.14% | 12.11% |
Dividend Yield | 1.18% | 1.09% | 1.19% | 2.71% | 4.09% | 4.65% |
Payout Ratio | - | 22.35% | 25.30% | 22.22% | 26.51% | 0.44% |
Total Shareholder Return | 1.19% | 1.09% | 1.19% | 2.71% | 4.09% | 4.65% |